🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a two stage study, with an initial dose escalation phase I study an...
Status
Active Not Recruiting
Location
Velindre NHS Trust
Start Date
2014-05-07
Trial ID
NCT01992952
Treatments Being Tested
This study is a Phase 1 dose-escalation open-label study to determine the r...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-05-04
Trial ID
NCT01138085
Treatments Being Tested
This phase I trial studies the side effects and the best dose of Akt inhibi...
Status
Active Not Recruiting
Location
Rutgers Cancer Institute of New Jersey
Start Date
2011-11-23
Trial ID
NCT01480154
Treatments Being Tested
This phase II trial studies how well trametinib and v-akt murine thymoma vi...
Status
Completed
Location
MedStar Georgetown University Hospital
Start Date
2013-10-02
Trial ID
NCT01964924
Treatments Being Tested
The multicenter, two-cohort, non-comparative, open-label, phase II clinical...
Status
Active Not Recruiting
Location
Hospital Universitario Clínico San Cecilio de Granada
Start Date
2023-05-24
Trial ID
NCT05810870
This phase II clinical trial studies how well Akt inhibitor MK2206 works in...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2010-12
Trial ID
NCT01258998
Treatments Being Tested
This research study is studying a combination of targeted therapies as a po...
Status
Recruiting
Location
Massachusetts General Hospital Cancer Center
Start Date
2018-12-24
Trial ID
NCT03675893
Treatments Being Tested
This study aims to determine whether adding an oral medication called Capiv...
Status
Not Yet Recruiting
Location
VA Connecticut Healthcare System West Haven Campus, West Haven, CT
Start Date
2026-10-01
Trial ID
NCT07793578
Treatments Being Tested
This is an open-label, multi-center, non-randomized, dose escalation Phase ...
Status
Completed
Location
M.D. Anderson Cancer Center
Start Date
2019-03-21
Trial ID
NCT02483858
Treatments Being Tested
This study will assess the efficacy and safety of capivasertib plus docetax...
Status
Active Not Recruiting
Location
Research Site
Start Date
2022-03-25
Trial ID
NCT05348577
Treatments Being Tested